Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing new medicines to improve the lives of people with cancer. We leverage our clinical-stage proprietary switch-control kinase inhibitor platform and expertise in kinase biology to develop a broad portfolio of innovative medicines.
